ArticleNature communications2025
Pathway-divergent coupling of alkynes and cyclobutenes through enantioselective cobalt catalysis.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recent trends of organic synthesis through cobalt metal-based catalysis: a review.RSC advances · 2026Review
- Phosphine-Catalyzed Unsymmetric [2 + 2] Annulation of Allenyl Phosphonates for Highly Substituted Cyclobutenes.Angewandte Chemie (International ed. in English) · 2026Article
- Catalytic Transformations of Aza-Cyclobutenes, Fused Cyclobutenes, and Cyclobutenones.Chemical record (New York, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Development of catalytic enantioselective transformations through divergent pathways from a single set of starting materials provides one of the most straightforward and efficient strategies for rapid establishment of a library of molecules in chemical synthesis and drug discovery. Catalytic reactions that generate enantioenriched cyclobutenes and cyclobutanes which are not only important units in medicinal chemistry, natural products and material science, but also useful intermediates in organic synthesis are of importance in the field of catalysis. Here we report a cobalt-catalyzed protocol for pathway-divergent enantioselective coupling of alkynes and cyclobutenes. Such processes that begin with oxidative cyclization followed by protonation or reductive elimination accurately controlled by ligands produce densely functionalized cyclobutanes and cyclobutenes in up to 95% yield with >98:2 regio- and diastereoselectivity and >99.5:0.5 enantiomeric ratio. Mechanistic studies and DFT calculations reveal that the reaction pathways are manipulated precisely by ligands and elucidate the origin of stereoselectivity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.